These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25433065)

  • 1. [Required knowledge for stroke specialists(5)medical treatment for secondary stroke prevention].
    Taguchi Y
    No Shinkei Geka; 2014 Dec; 42(12):1159-71. PubMed ID: 25433065
    [No Abstract]   [Full Text] [Related]  

  • 2. Filling the gap between science & clinical practice: prevention of stroke recurrence.
    Russolillo A; Di Minno MN; Tufano A; Prisco D; Di Minno G
    Thromb Res; 2012 Jan; 129(1):3-8. PubMed ID: 21907395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stroke: secondary prevention].
    Gubitz G; Lip G; Sudlow C; Sandercock P
    Vasa; 2004 May; 33(2):110-3; discussion 114. PubMed ID: 15224467
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug treatments in the secondary prevention of ischaemic stroke.
    Schulz UG
    Maturitas; 2013 Nov; 76(3):267-71. PubMed ID: 23769546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.
    Martí-Fàbregas J; Mateo J
    Cerebrovasc Dis; 2009; 27 Suppl 1():111-9. PubMed ID: 19342840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic interventions and success in risk factor control for secondary prevention of stroke.
    Alvarez-Sabin J; Quintana M; Hernandez-Presa MA; Alvarez C; Chaves J; Ribo M
    J Stroke Cerebrovasc Dis; 2009; 18(6):460-5. PubMed ID: 19900649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary prevention of stroke.
    Cardiovasc J Afr; 2009; 20(2):147-8. PubMed ID: 19421656
    [No Abstract]   [Full Text] [Related]  

  • 8. Standard medical management in secondary prevention of ischemic stroke in China (SMART).
    Peng B; Zhu Y; Cui L; Ni J; Xu W; Zhou L; Yao M; Chen L; Wang J; Wang Y; Pu C;
    Int J Stroke; 2011 Oct; 6(5):461-5. PubMed ID: 21951412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Patent foramen ovale and stroke].
    Mono ML; Nedeltchev K
    Fortschr Neurol Psychiatr; 2012 May; 80(5):288-99. PubMed ID: 22566139
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiology patient page. Heart disease prevention in women. American Heart Association.
    Mosca L
    Circulation; 2004 Mar; 109(10):e158-60. PubMed ID: 15023896
    [No Abstract]   [Full Text] [Related]  

  • 11. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention.
    Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
    Thromb Haemost; 2009 Feb; 101(2):367-72. PubMed ID: 19190823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.
    Weber R; Weimar C; Diener HC
    Expert Opin Pharmacother; 2009 Aug; 10(12):1883-94. PubMed ID: 19558342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional wisdom vs reality in stroke prevention.
    Barnett HJ
    Neurology; 2005 Apr; 64(7):1122-4. PubMed ID: 15824332
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical prophylaxis following hospitalization for ischemic stroke: age- and sex-related differences and relation to mortality.
    Palnum KH; Mehnert F; Andersen G; Ingeman A; Krog BR; Bartels PD; Johnsen SP
    Cerebrovasc Dis; 2010; 30(6):556-66. PubMed ID: 20948199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of oral anticoagulation for secondary stroke prevention.
    Stöllberger C; Finsterer J
    Eur J Neurol; 2009 Oct; 16(10):1075-6. PubMed ID: 19614970
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiocoagulation for the secondary prevention of ischemic stroke].
    Alegría MA; Arauz A; Roa LF; Márquez J; Calleja J; Leyva A; Cantú C; Barinagarrementeria F; Ruiz-Sandoval JL; Villarreal J; Romano J; Merino JG; Murillo L; Escamilla JM;
    Rev Invest Clin; 2010; 62(2):141-51. PubMed ID: 20597394
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neuropharmacological overview - 2012].
    Bereczki D
    Neuropsychopharmacol Hung; 2012 Jun; 14(2):74-5. PubMed ID: 22710848
    [No Abstract]   [Full Text] [Related]  

  • 18. Antithrombotic therapies in cerebrovascular disease: what should we use as secondary prevention in patients with carotid artery disease?
    Beckman JA
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S12-6. PubMed ID: 19530155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent clinical trials of antiplatelet therapy in secondary stroke prevention: expectations and results for application in primary care settings.
    Lutsep HL
    Am J Med; 2009 Apr; 122(4 Suppl 2):S21-31. PubMed ID: 19332240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention.
    Peterson GM; Boom K; Jackson SL; Vial JH
    Intern Med J; 2002; 32(1-2):15-23. PubMed ID: 11783668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.